Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,881-2,892 of 4,306
Drug study icon
Active Not RecruitingNCT05622201

A Controlled study With Rituximab for Psychotic Disorder in Adults

This study is active but not recruiting in Sweden. It focuses on Schizophrenia.

In Örebro
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
Sweden
Sponsor
Region Örebro County
Condition
Schizophrenia
Drug study icon
TerminatedNCT03044249

MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

This study was terminated in the United States and in Canada. It is testing MP-101 for Schizophrenia.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 50 Years
Countries
United States, Canada
Sponsor
Mediti Pharma Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00658567

Safety study of safety and Efficacy of Pimavanserin in Schizophrenia

This study is completed in the United States, in Belgium, in Austria, .... It is testing safety and Efficacy of Pimavanserin for Schizophrenia.

Multiple locations, including La Habra
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 40 Years
Countries
United States, Belgium, Austria, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02430935

Effectiveness of cognitive Adaptation Training in Schizophrenia

This study is completed in Canada. It is testing cognitive Adaptation Training for Schizophrenia.

In Toronto
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 16 Years to 29 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Drug study icon
CompletedNCT00644800

Intramuscular Ziprasidone Followed by Oral Ziprasidone for Schizophrenia

This study is completed in Brazil. It is testing intramuscular Ziprasidone Followed by Oral Ziprasidone for Schizophrenia.

Multiple locations, including Fortaleza
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrugFrom 18 Years to 55 Years
Countries
Brazil
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00477672

Safety study of safety and Efficacy of Pimavanserin in Schizophrenia

This study is completed in the United States, in France, in the United Kingdom, .... It is testing safety and Efficacy of Pimavanserin for Schizophrenia.

Multiple locations, including Gilbert
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 40 Years
Countries
United States, France, United Kingdom, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02035553

Safety study of safety and Efficacy of Pimavanserin in Schizophrenia

This study is completed in the United Kingdom. It is testing safety and Efficacy of Pimavanserin for Schizophrenia.

In London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 50 Years
Countries
United Kingdom
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00550238

Safety study of pimavanserin in Schizophrenia

This study is completed in the United States, in France, in Canada, .... It is testing pimavanserin for Schizophrenia.

Multiple locations, including Gilbert
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 40 Years
Countries
United States, France, Canada, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03814122

Action-based Cognitive Remediation for First Episode Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Winnipeg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 37 Years
Countries
Canada
Sponsor
University of Manitoba
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.